These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18332170)

  • 1. Pharmacodynamic analysis and clinical trial of amoxicillin sprinkle administered once daily for 7 days compared to penicillin V potassium administered four times daily for 10 days in the treatment of tonsillopharyngitis due to Streptococcus pyogenes in children.
    Pichichero ME; Casey JR; Block SL; Guttendorf R; Flanner H; Markowitz D; Clausen S
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2512-20. PubMed ID: 18332170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
    Syrogiannopoulos GA; Bozdogan B; Grivea IN; Ednie LM; Kritikou DI; Katopodis GD; Beratis NG; Applebaum PC;
    Pediatr Infect Dis J; 2004 Sep; 23(9):857-65. PubMed ID: 15361727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin pulsatile - MiddleBrook: APC 111, APC-111, PULSYS-enhanced amoxicillin.
    Drugs R D; 2007; 8(6):395-9. PubMed ID: 17963430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Six-day amoxicillin vs. ten-day penicillin V therapy for group A streptococcal tonsillopharyngitis.
    Cohen R; Levy C; Doit C; De La Rocque F; Boucherat M; Fitoussi F; Langue J; Bingen E
    Pediatr Infect Dis J; 1996 Aug; 15(8):678-82. PubMed ID: 8858671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of dosing frequency on the efficacy of 10-day penicillin or amoxicillin therapy for streptococcal tonsillopharyngitis: A meta-analysis.
    Lan AJ; Colford JM; Colford JM
    Pediatrics; 2000 Feb; 105(2):E19. PubMed ID: 10654979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
    Takker U; Dzyublyk O; Busman T; Notario G
    Curr Med Res Opin; 2003; 19(5):421-9. PubMed ID: 13678479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explaining the poor bacteriologic eradication rate of single-dose ceftriaxone in group a streptococcal tonsillopharyngitis: a reverse engineering solution using pharmacodynamic modeling.
    Blumer JL; Reed MD; Kaplan EL; Drusano GL
    Pediatrics; 2005 Oct; 116(4):927-32. PubMed ID: 16199703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
    Cohen R; Reinert P; De La Rocque F; Levy C; Boucherat M; Robert M; Navel M; Brahimi N; Deforche D; Palestro B; Bingen E
    Pediatr Infect Dis J; 2002 Apr; 21(4):297-303. PubMed ID: 12075760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children.
    Pichichero ME; Gooch WM; Rodriguez W; Blumer JL; Aronoff SC; Jacobs RF; Musser JM
    Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1053-60. PubMed ID: 7921095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily therapy for streptococcal pharyngitis with amoxicillin.
    Feder HM; Gerber MA; Randolph MF; Stelmach PS; Kaplan EL
    Pediatrics; 1999 Jan; 103(1):47-51. PubMed ID: 9917438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis.
    Curtin-Wirt C; Casey JR; Murray PC; Cleary CT; Hoeger WJ; Marsocci SM; Murphy ML; Francis AB; Pichichero ME
    Clin Pediatr (Phila); 2003 Apr; 42(3):219-25. PubMed ID: 12739920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
    Norrby SR; Quinn J; Rangaraju M; Leroy B
    Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily amoxicillin versus twice-daily penicillin V in group A beta-haemolytic streptococcal pharyngitis.
    Lennon DR; Farrell E; Martin DR; Stewart JM
    Arch Dis Child; 2008 Jun; 93(6):474-8. PubMed ID: 18337284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis].
    Adam D; Scholz H; Helmerking M
    Fortschr Med Orig; 2001 Jul; 119 Suppl 2():63-70. PubMed ID: 15704358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
    O'Doherty B
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis.
    Disney FA; Hanfling MJ; Hausinger SA
    Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S20-6. PubMed ID: 1513608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial.
    Clegg HW; Ryan AG; Dallas SD; Kaplan EL; Johnson DR; Norton HJ; Roddey OF; Martin ES; Swetenburg RL; Koonce EW; Felkner MM; Giftos PM
    Pediatr Infect Dis J; 2006 Sep; 25(9):761-7. PubMed ID: 16940830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cefdinir and penicillin V in the treatment of pediatric streptococcal tonsillopharyngitis.
    Pichichero ME; Gooch WM
    Pediatr Infect Dis J; 2000 Dec; 19(12 Suppl):S171-3. PubMed ID: 11144400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.
    Skoog Ståhlgren G; Tyrstrup M; Edlund C; Giske CG; Mölstad S; Norman C; Rystedt K; Sundvall PD; Hedin K
    BMJ; 2019 Oct; 367():l5337. PubMed ID: 31585944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.